Pfizer Overview

  • Founded
  • 1848
Founded
  • Status
  • Public
  • Employees
  • 79,000
Employees
  • Stock Symbol
  • PFE
Stock Symbol
  • Investments
  • 115
  • Share Price
  • $52.47
  • (As of Friday Closing)

Pfizer General Information

Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.

Contact Information

Website
www.pfizer.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Discovery Tools (Healthcare)
Stock Exchange
NYS
Primary Office
  • 235 East 42nd Street
  • New York, NY 10017
  • United States
+1 (212) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pfizer Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$52.47 $50.65 $38.48 - $61.71 $294B 5.61B 28.1M $4.44

Pfizer Financials Summary

In Thousands,
USD 		TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 298,576,284 340,426,773 255,869,579 260,704,914
Revenue 92,367,000 81,288,000 41,651,000 40,905,000
EBITDA 34,076,000 30,757,000 13,189,000 18,424,000
Net Income 24,966,000 21,979,000 9,159,000 16,026,000
Total Assets 183,841,000 181,476,000 154,229,000 167,594,000
Total Debt 35,052,000 36,998,000 38,274,000 50,840,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pfizer Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pfizer‘s full profile, request access.

Request a free trial

Pfizer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 va
Pharmaceuticals
New York, NY
79,000 As of 2021
000000000-00

00000000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
000000000000000
Brentford, United Kingdom
00000 As of 0000
000000000

00000000

lit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sun
000000000000000
Basel, Switzerland
000000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pfizer Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlaxoSmithKline Corporation Brentford, United Kingdom 00000 000000000
00000000 Corporation Basel, Switzerland 000000 000000000000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
0000 0000000 Corporation Bagsvaerd, Denmark 00000 000000000
000 000000 Corporate Backed or Acquired Monheim, Germany 0000 000000&0
You’re viewing 5 of 10 competitors. Get the full list »

Pfizer Patents

  • 39,753

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 358

    Granted

  • 256

    Pending

  • 000

    Expiring in next 12 mo

Pfizer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210268095-A1 Escherichia coli compositions and methods thereof Pending 23-Feb-2020 0000000000
US-20210246213-A1 Anti-e-selectin antibodies, compositions and methods of use Pending 24-Jan-2020 00000000000
CA-3103120-A1 Chemical compounds Pending 20-Dec-2019 0000000000
US-20210188829-A1 Chemical compounds Pending 20-Dec-2019 000000000
US-20210179716-A1 Antibodies specific for cd47, pd-l1, and uses thereof Pending 17-Dec-2019 C07K16/2827
To view Pfizer’s complete patent history, request access »

Pfizer Executive Team (332)

Name Title Board Seat Contact Info
Albert Bourla Ph.D Chief Executive Officer & Chairman
Andy Schmeltz Global President & General Manager, Pfizer Oncology
Mikael Dolsten Ph.D Chief Scientific Officer & President, Worldwide Research, Development and Medical
Mike Gladstone Global President of Inflammation & Immunology
Nick Lagunowich Global President, Pfizer Internal Medicine
You’re viewing 5 of 332 executive team members. Get the full list »

Pfizer Board Members (23)

Name Representing Role Since
000000 000000 00.0 Pfizer Chief Executive Officer & Chairman 000 0000
000 0000000 00.0 Pfizer Board Member 000 0000
00000 0000000 Pfizer Director, Portfolio Director & Planning Lead, PMP, Pfizer Oncology 000 0000
00000 00000 00.0 Pfizer Board Member 000 0000
00000 00000 Self Board Member 000 0000
You’re viewing 5 of 23 board members. Get the full list »

Pfizer Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pfizer Investments & Acquisitions (115)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 10-May-2022 0000000000 000.00 Drug Discovery 0000 0000
00000 02-May-2022 0000 00000 Outcome Management (Healthcare)
00000000 0000 28-Apr-2022 0000 0000 Drug Discovery 00000 000
0000000 07-Apr-2022 0000000000 00000 Drug Discovery 000000 00
Arena Pharmaceuticals 11-Mar-2022 Merger/Acquisition 00.00 Drug Discovery 0000 0000
You’re viewing 5 of 115 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Pfizer Subsidiaries (18)

Company Name Industry Location Founded
InnoPharma Pharmaceuticals Piscataway Township, NJ 2005
0000000 000(0) 000 Corporate Pension Peapack, NJ 0000
000000 00000000 Corporate Venture Capital New York, NY 0000
00000 000000000 Biotechnology Boulder, CO 0000
0000000 000000 000 Personal Products Guangzhou, China 0000
You’re viewing 5 of 18 subsidiaries. Get the full list »

Pfizer Exits (30)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 29-Oct-2020 00000 00000 00 00000 Completed
  • 15 buyers
0000000 0000000000 01-Nov-2017 000000000 00000 Completed
  • 000000
00 000000 00000000 13-Dec-2016 000000000 Completed
  • 000000
0000000 00000000 27-Oct-2016 000 00000 Completed
  • 3 buyers
Gemphire Therapeutics 04-Aug-2016 IPO 0000 Completed
  • 5 buyers
You’re viewing 5 of 30 exits. Get the full list »